The prevalence of ocular diseases such glaucoma, cataracts, and diabetic retinopathy is predicted to increase, which will boost overall growth. Additionally, at least 1 billion patients worldwide have untreated or preventable vision impairments, which is likely to fuel the industry's overall growth.
